SCHEMBL13340285

SCHEMBL13340285

Cc1ccc(-c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3c4ccccc4c4ccccc4c3c2-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
GPR84 Q9NQS5 2/20 0.35
ACHE P22303 1/20 0.35
KDM4E B2RXH2 7/20 0.34
PPARG P37231 2/20 0.34
POLB P06746 1/20 0.34
MCL1 Q07820 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
HPRT1 P00492 1/20 0.34
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
ALDH1A1 P00352 5/20 0.33
HPGD P15428 4/20 0.32
HSD17B10 Q99714 2/20 0.32
HTT P42858 1/20 0.32
GFER P55789 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
CRHR1 P34998 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13340318 0.99 GPR84 (0.36) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13340287 0.99 GPR84 (0.36) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13340310 0.99 MAPT (0.37) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13339968 0.95 MAPT (0.34) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13339812 0.95 MAPT (0.34) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13340128 0.95 MAPT (0.34) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13340130 0.95 MAPT (0.34) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13339949 0.95 MAPT (0.34) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13340134 0.94 MAPT (0.33) MAPTGPR84ACHEKDM4EPPARG
SCHEMBL13339950 0.94 MAPT (0.34) MAPTGPR84ACHEKDM4EPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 MAPT 3478/4885GPR84 994/4885ACHE 2234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.